The FDA-approved smoking cessation pill, varenicline, has emerged as a critical tool in combating nicotine addiction, especially among teens and young adults.Recent research reveals that this twice-daily medication significantly boosts the chances of quitting vaping, with participants enjoying three times the success rate compared to those on placebo.